| # | Drug | Count |
|---|---|---|
| 0 | FLUCONAZOLE | 18 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 15 |
| 2 | VANCOMYCIN | 14 |
| 3 | CIPROFLOXACIN | 13 |
| 4 | CIPROFLOXACIN HYDROCHLORIDE | 13 |
| 5 | METRONIDAZOLE | 10 |
| 6 | METRONIDAZOLE TOPICAL | 10 |
| 7 | CIPROFLOXACIN TABLETS | 9 |
| 8 | CIPROFOLXACIN | 9 |
| 9 | LINEZOLID | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMPICILLIN AND SULBACTAM | 7 | 0.0080 |
| 1 | CEFTOLOZANE AND TAZOBACTAM | 4 | 0.0041 |
| 2 | MILRINONE LACTATE | 1 | 0.0036 |
| 3 | NAFCILLIN SODIUM | 3 | 0.0033 |
| 4 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 7 | 0.0027 |
| 5 | SODIUM NITROPRUSSIDE | 1 | 0.0026 |
| 6 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 7 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 5 | 0.0021 |
| 8 | CEFPODOXIME PROXETIL | 2 | 0.0020 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 15 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 27 |
| 1 | Azole Antifungal [EPC] | 26 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 18 |
| 3 | Glycopeptide Antibacterial [EPC] | 15 |
| 4 | Fluoroquinolone Antibacterial [EPC] | 13 |
| 5 | Proton Pump Inhibitor [EPC] | 13 |
| 6 | Nitroimidazole Antimicrobial [EPC] | 10 |
| 7 | Aminoglycoside Antibacterial [EPC] | 9 |
| 8 | Loop Diuretic [EPC] | 9 |
| 9 | Oxazolidinone Antibacterial [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 5 | 0.0021 |
| 1 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Echinocandin Antifungal [EPC] | 6 | 0.0007 |
| 3 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 4 | Recombinant Human Deoxyribonuclease 1 [EPC] | 6 | 0.0003 |
| 5 | Oxazolidinone Antibacterial [EPC] | 9 | 0.0003 |
| 6 | Penem Antibacterial [EPC] | 9 | 0.0003 |
| 7 | Bile Acid [EPC] | 6 | 0.0003 |
| 8 | Tetracycline-class Antibacterial [EPC] | 2 | 0.0003 |
| 9 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |